Schoeneck James A

CIK 00014209874 companiesMENLO PARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001420987

Recent Transactions

50 trades

Purchase
Calidi Biotherapeutics, Inc.$CLDI
Common Stock
2025-08-21$2.00/sh+75,000→ 76,134 total
Purchase
Calidi Biotherapeutics, Inc.$CLDI
Warrant (right to buy)
2025-08-21+75,000→ 75,000 total
Award
Calidi Biotherapeutics, Inc.$CLDI
Non-Qualified Stock Options (right to buy)
2025-07-09+164,493→ 164,493 total
Purchase
FIBROGEN INC$FGEN
Common Stock
2025-06-30$5.07/sh+23,567→ 39,666 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2025-06-04+120,000→ 120,000 total
Purchase
FIBROGEN INC$FGEN
Common Stock
2025-03-21$0.34/sh+50,000→ 373,722 total
Purchase
FIBROGEN INC$FGEN
Common Stock
2025-03-20$0.35/sh+250,000→ 323,722 total
Award
Calidi Biotherapeutics, Inc.$CLDI
Non-Qualified Stock Options (right to buy)
2024-09-20+20,217→ 20,217 total
Award
Calidi Biotherapeutics, Inc.$CLDI
Common Stock
2024-06-28+79,687→ 1,071,781 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2024-06-05+70,000→ 70,000 total
Exercise/Conversion
Calidi Biotherapeutics, Inc.$CLDI
Warrants
2024-06-03+375,000→ 375,000 total
Exercise/Conversion
Calidi Biotherapeutics, Inc.$CLDI
Warrants
2024-06-03+173,000→ 173,000 total
Exercise/Conversion
Calidi Biotherapeutics, Inc.$CLDI
Warrants
2024-06-03−375,000→ 0 total
Exercise/Conversion
Calidi Biotherapeutics, Inc.$CLDI
Warrants
2024-06-03−173,000→ 202,000 total
Exercise/Conversion
Calidi Biotherapeutics, Inc.$CLDI
Common Stock
2024-06-03$0.20/sh+375,000→ 963,887 total
Award
Calidi Biotherapeutics, Inc.$CLDI
Warrants
2024-06-03+548,000→ 548,000 total
Exercise/Conversion
Calidi Biotherapeutics, Inc.$CLDI
Common Stock
2024-06-03$0.20/sh+173,000→ 588,887 total
Award
Calidi Biotherapeutics, Inc.$CLDI
Warrants
2024-04-18+375,000→ 375,000 total
Award
Calidi Biotherapeutics, Inc.$CLDI
Warrants
2024-04-18+375,000→ 375,000 total
Award
Calidi Biotherapeutics, Inc.$CLDI
Warrants
2024-04-18+375,000→ 375,000 total
Award
Calidi Biotherapeutics, Inc.$CLDI
Common Stock
2024-04-18$0.40/sh+375,000→ 415,887 total
Award
Calidi Biotherapeutics, Inc.$CLDI
Common Stock
2024-03-29+28,207→ 992,094 total
Award
Calidi Biotherapeutics, Inc.$CLDI
Common Stock
2023-12-21$1.80/sh+10,625→ 27,872 total
Award
Calidi Biotherapeutics, Inc.$CLDI
Non-Qualified Stock Options (right to buy)
2023-12-21+70,249→ 70,249 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2023-08-10+10,000→ 10,000 total
Award
FIBROGEN INC$FGEN
Common Stock
2023-06-07+8,289→ 28,766 total
Sale
FIBROGEN INC$FGEN
Common Stock
2023-06-07$18.03/sh−7,100→ 73,722 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2023-06-07+12,666→ 12,666 total
Award
FIBROGEN INC$FGEN
Common Stock
2022-06-16+15,777→ 20,477 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2022-06-16+25,684→ 25,684 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2021-05-26+7,800→ 7,800 total
Award
FIBROGEN INC$FGEN
Common Stock
2021-05-26+4,700→ 14,100 total
Exercise/Conversion
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2021-01-04−6,000→ 0 total
Exercise/Conversion
FIBROGEN INC$FGEN
Common Stock
2021-01-04$9.78/sh+6,000→ 15,400 total
Exercise/Conversion
FIBROGEN INC$FGEN
Common Stock
2020-08-20$5.95/sh+6,000→ 15,400 total
Exercise/Conversion
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2020-08-20−6,000→ 0 total
Award
FIBROGEN INC$FGEN
Common Stock
2020-06-04+4,700→ 9,400 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2020-06-04+7,800→ 7,800 total
Tax Payment
FIBROGEN INC$FGEN
Common Stock
2020-01-06$43.35/sh−10,928→ 22,422 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2019-09-18+97,100→ 97,100 total
Award
FIBROGEN INC$FGEN
Common Stock
2019-09-18+57,300→ 62,000 total
Award
FIBROGEN INC$FGEN
Common Stock
2019-06-05+4,700→ 22,400 total
Award
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2019-06-05+7,800→ 7,800 total
Exercise/Conversion
FIBROGEN INC$FGEN
Common Stock
2019-05-28$2.90/sh+2,000→ 5,700 total
Exercise/Conversion
FIBROGEN INC$FGEN
Common Stock
2019-05-28$3.50/sh+12,000→ 17,700 total
Exercise/Conversion
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2019-05-28−2,000→ 0 total
Exercise/Conversion
FIBROGEN INC$FGEN
Stock Option (Right to Buy)
2019-05-28−12,000→ 0 total
Sale
FIBROGEN INC$FGEN
Common Stock
2019-05-07$47.69/sh−500→ 3,700 total
Exercise/Conversion
FIBROGEN INC$FGEN
Common Stock
2019-05-07$2.90/sh+2,000→ 5,700 total
Sale
FIBROGEN INC$FGEN
Common Stock
2019-05-07$46.80/sh−1,500→ 4,200 total

Companies

Recent Filings

Address

C/O DEPOMED 1360 O'BRIEN DR.

MENLO PARK, CA, 94025

View on SEC.gov